Drug Information

Drug General Information
Drug ID
D0FQ2U
Former ID
DIB005907
Drug Name
Talabostat
Synonyms
Talabostat mesylate; Boroproline compounds, DARA BioSciences; Boroproline compounds, Point Therapeutics; PT-100; Val-boro-Pro
Drug Type
Small molecular drug
Indication Hematopoietic [ICD10:D50-D89] Phase 3 [529167]
Company
Point Therapeutics; Tufts University School of Medicine
Formula
C9H19BN2O3
Canonical SMILES
N1(C(=O)[C@@H](N)C(C)C)[C@H](B(O)O)CCC1
CAS Number
CAS 150080-09-4
PubChem Compound ID
49853489
Target and Pathway
Target(s) Seprase Target Info Inhibitor [529167]
References
Ref 529167Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer. Cancer Biol Ther. 2007 Nov;6(11):1691-9. Epub 2007 Aug14.
Ref 529167Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer. Cancer Biol Ther. 2007 Nov;6(11):1691-9. Epub 2007 Aug14.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.